NCT06850506View on ClinicalTrials.gov

Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

Active, not recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
SarcomaSarcoma, BoneEwing SarcomaOsteosarcoma
Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER